KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Pension (2016 - 2025)

West Pharmaceutical Services' Pension history spans 17 years, with the latest figure at $31.1 million for Q3 2025.

  • For Q3 2025, Pension rose 2.98% year-over-year to $31.1 million; the TTM value through Sep 2025 reached $31.1 million, up 2.98%, while the annual FY2024 figure was $28.2 million, 4.73% down from the prior year.
  • Pension for Q3 2025 was $31.1 million at West Pharmaceutical Services, up from $30.8 million in the prior quarter.
  • Across five years, Pension topped out at $54.0 million in Q2 2021 and bottomed at $27.3 million in Q2 2023.
  • The 5-year median for Pension is $29.9 million (2023), against an average of $33.0 million.
  • The largest annual shift saw Pension crashed 30.37% in 2022 before it rose 6.59% in 2024.
  • A 5-year view of Pension shows it stood at $40.5 million in 2021, then plummeted by 30.37% to $28.2 million in 2022, then rose by 4.96% to $29.6 million in 2023, then dropped by 4.73% to $28.2 million in 2024, then increased by 10.28% to $31.1 million in 2025.
  • Per Business Quant, the three most recent readings for WST's Pension are $31.1 million (Q3 2025), $30.8 million (Q2 2025), and $28.6 million (Q1 2025).